Traws Pharma (TRAW) Return on Equity [ROE] (2013 - 2025)
Traws Pharma's Return on Equity [ROE] was -912.92% in Q4 2025, down 666.42 percentage points from the prior quarter.
Powered by 
Analysis
Traws Pharma (TRAW) Return on Equity [ROE] (2013 - 2025) Analysis & Trends
For FY2023, Return on Equity [ROE] at Traws Pharma came in at -97.22%, down 46.26 percentage points from FY2022.
- Return on Equity [ROE] shows a four-year change of +156.34 percentage points (FY2019 to FY2023).
- In earlier years, Return on Equity [ROE] was -50.96% in FY2022 (+10.86 pp), -61.81% in FY2021 (+221.66 pp), -283.48% in FY2020 (-29.92 pp) and -253.56% in FY2019.
- The Q4 2025 figure marks the lowest quarterly Return on Equity [ROE] since Q1 2019.
- The best year-over-year quarter for Return on Equity [ROE] over five years was Q4 2021 (a gain of 239.85 percentage points); the worst was Q1 2024 (a drop of 137.05 percentage points).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 82.09% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 25.32% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | - |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 7.21% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 84.40% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 21.39% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 83.75% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -18.38% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 4.97% |
| 10 | Traws Pharma | 5.79 Mn | -12.60 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -912.92% |
| Sep 30, 2025 | -246.51% |
| Jun 30, 2025 | -284.20% |
| Mar 31, 2024 | -217.61% |
| Dec 31, 2023 | -150.45% |
| Sep 30, 2023 | -120.81% |
| Jun 30, 2023 | -99.79% |
| Mar 31, 2023 | -80.56% |
| Dec 31, 2022 | -61.49% |
| Sep 30, 2022 | -48.17% |
| Jun 30, 2022 | -38.04% |
| Mar 31, 2022 | -35.22% |
| Dec 31, 2021 | -33.75% |
| Sep 30, 2021 | -45.56% |
| Jun 30, 2021 | -61.63% |
| Mar 31, 2021 | -114.38% |
| Dec 31, 2020 | -273.59% |
| Sep 30, 2020 | -175.78% |
| Jun 30, 2020 | -123.46% |
| Mar 31, 2020 | -115.39% |
API Access
Traws Pharma Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=TRAW&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "TRAW", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=TRAW&period=max&api_key=YOUR_API_KEY");
const data = await res.json();